8-6621521-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_024596.5(MCPH1):​c.2282C>T​(p.Ala761Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.419 in 1,613,234 control chromosomes in the GnomAD database, including 143,781 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A761G) has been classified as Benign.

Frequency

Genomes: 𝑓 0.43 ( 14463 hom., cov: 33)
Exomes 𝑓: 0.42 ( 129318 hom. )

Consequence

MCPH1
NM_024596.5 missense

Scores

14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11O:1

Conservation

PhyloP100: -0.503

Publications

46 publications found
Variant links:
Genes affected
MCPH1 (HGNC:6954): (microcephalin 1) This gene encodes a DNA damage response protein. The encoded protein may play a role in G2/M checkpoint arrest via maintenance of inhibitory phosphorylation of cyclin-dependent kinase 1. Mutations in this gene have been associated with primary autosomal recessive microcephaly 1 and premature chromosome condensation syndrome. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2010]
MCPH1-AS1 (HGNC:51655): (MCPH1 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.4113652E-6).
BP6
Variant 8-6621521-C-T is Benign according to our data. Variant chr8-6621521-C-T is described in ClinVar as Benign. ClinVar VariationId is 21702.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.653 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024596.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MCPH1
NM_024596.5
MANE Select
c.2282C>Tp.Ala761Val
missense
Exon 13 of 14NP_078872.3
MCPH1
NM_001322042.2
c.2282C>Tp.Ala761Val
missense
Exon 13 of 15NP_001308971.2
MCPH1
NM_001410917.1
c.2282C>Tp.Ala761Val
missense
Exon 13 of 14NP_001397846.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MCPH1
ENST00000344683.10
TSL:1 MANE Select
c.2282C>Tp.Ala761Val
missense
Exon 13 of 14ENSP00000342924.5
MCPH1
ENST00000692836.1
c.2282C>Tp.Ala761Val
missense
Exon 13 of 13ENSP00000509971.1
MCPH1
ENST00000689348.1
c.2282C>Tp.Ala761Val
missense
Exon 13 of 15ENSP00000509554.1

Frequencies

GnomAD3 genomes
AF:
0.432
AC:
65663
AN:
151916
Hom.:
14441
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.470
Gnomad AMI
AF:
0.326
Gnomad AMR
AF:
0.392
Gnomad ASJ
AF:
0.343
Gnomad EAS
AF:
0.672
Gnomad SAS
AF:
0.494
Gnomad FIN
AF:
0.408
Gnomad MID
AF:
0.367
Gnomad NFE
AF:
0.406
Gnomad OTH
AF:
0.432
GnomAD2 exomes
AF:
0.433
AC:
108048
AN:
249372
AF XY:
0.434
show subpopulations
Gnomad AFR exome
AF:
0.472
Gnomad AMR exome
AF:
0.398
Gnomad ASJ exome
AF:
0.339
Gnomad EAS exome
AF:
0.662
Gnomad FIN exome
AF:
0.410
Gnomad NFE exome
AF:
0.401
Gnomad OTH exome
AF:
0.407
GnomAD4 exome
AF:
0.417
AC:
609561
AN:
1461200
Hom.:
129318
Cov.:
52
AF XY:
0.419
AC XY:
304878
AN XY:
726940
show subpopulations
African (AFR)
AF:
0.477
AC:
15954
AN:
33464
American (AMR)
AF:
0.397
AC:
17743
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.336
AC:
8781
AN:
26136
East Asian (EAS)
AF:
0.676
AC:
26842
AN:
39700
South Asian (SAS)
AF:
0.496
AC:
42757
AN:
86254
European-Finnish (FIN)
AF:
0.417
AC:
22262
AN:
53376
Middle Eastern (MID)
AF:
0.416
AC:
2398
AN:
5768
European-Non Finnish (NFE)
AF:
0.403
AC:
447739
AN:
1111418
Other (OTH)
AF:
0.416
AC:
25085
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
21394
42789
64183
85578
106972
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13996
27992
41988
55984
69980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.432
AC:
65728
AN:
152034
Hom.:
14463
Cov.:
33
AF XY:
0.436
AC XY:
32366
AN XY:
74304
show subpopulations
African (AFR)
AF:
0.470
AC:
19492
AN:
41484
American (AMR)
AF:
0.393
AC:
5998
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.343
AC:
1189
AN:
3470
East Asian (EAS)
AF:
0.672
AC:
3468
AN:
5162
South Asian (SAS)
AF:
0.494
AC:
2381
AN:
4824
European-Finnish (FIN)
AF:
0.408
AC:
4311
AN:
10558
Middle Eastern (MID)
AF:
0.367
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
0.406
AC:
27574
AN:
67944
Other (OTH)
AF:
0.431
AC:
910
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1923
3846
5768
7691
9614
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
606
1212
1818
2424
3030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.415
Hom.:
62238
Bravo
AF:
0.433
TwinsUK
AF:
0.382
AC:
1416
ALSPAC
AF:
0.394
AC:
1517
ESP6500AA
AF:
0.444
AC:
1888
ESP6500EA
AF:
0.392
AC:
3316
ExAC
AF:
0.436
AC:
52750
Asia WGS
AF:
0.530
AC:
1846
AN:
3478
EpiCase
AF:
0.399
EpiControl
AF:
0.395

ClinVar

Significance: Benign
Submissions summary: Benign:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Microcephaly 1, primary, autosomal recessive Benign:4Other:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

not specified Benign:4
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Apr 10, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Aug 02, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:3
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 18204051)

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
0.18
DANN
Benign
0.70
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.0056
N
MetaRNN
Benign
0.0000034
T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.50
PrimateAI
Benign
0.25
T
PROVEAN
Benign
0.91
N
REVEL
Benign
0.18
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Vest4
0.011
ClinPred
0.0058
T
GERP RS
-8.3
Varity_R
0.031
gMVP
0.26
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1057090; hg19: chr8-6479042; COSMIC: COSV60910792; COSMIC: COSV60910792; API